Press Releases

Avedro Inc. a Boston-based ophthalmic medical device and pharmaceutical company announces today that the first patients have been treated in two new US clinical trials: Lasik with Cross-linking and Pulsed Accelerated Cross-linking. Lasik with cross-linking...

Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces the formal launch of HypoxyLab™ – the industry’s first benchtop, HEPA-filtered, precision-controlled hypoxia workstation. HypoxyLab creates...

Promethera Biosciences has conducted the trial in Belgium, France, United Kingdom, Italy and Israel, treating twenty patients affected by very rare liver-based metabolic diseases. Promethera Biosciences, a Belgian biotechnology company developing Promethera(R) HepaStem, a cell-based...

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.  ...

Covance Inc. , one of the world's largest and most comprehensive drug development companies, and PathoQuest, a pioneer in the field of pathogen detection, today announce an exclusive agreement to collaborate in providing Next-Generation Sequencing (NGS) based biosafety assessments. ...

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed its efficacy study of olesoxime in the rare neurodegenerative condition Spinal Muscular Atrophy...

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology. MedImmune has also entered into...